Results 251 to 260 of about 255,505 (337)

Symptom Clusters in Patients With Bone Metastases: A Sub-Analysis of Patients Reporting Exclusively Non-Zero BPI Scores

, 2012
Cramarossa
openalex   +2 more sources

Surgical Outcomes and Recurrence Management in Borderline Resectable Hepatocellular Carcinoma: Implications for Multidisciplinary Strategies

Annals of Gastroenterological Surgery, EarlyView.
Multivariate analysis identified that up‐to‐7 out (p < 0.001), lymph node metastasis (p < 0.001), and non‐anatomical resection (p = 0.02) were independent predictors of cancer recurrence, while older age (p = 0.01), Child‐Pugh B (p < 0.001), up‐to‐7 out (p = 0.01), macrovascular invasion (p = 0.01), and lymph node metastasis (p < 0.001) were ...
Koichiro Haruki, Kenei Furukawa, Munetoshi Akaoka, Yuto Yamahata, Shinji Onda, Yoshihiro Shirai, Masashi Tsunematsu, Tomohiko Taniai, Michinori Matsumoto, Toru Ikegami   +9 more
wiley   +1 more source

Anatomical-biochemical discordance and prognostic role of bone metastases in advanced MTC treated with [¹⁷⁷Lu]Lu-DOTA-TATE. [PDF]

BMC Cancer
Bilgic S, Nazari A, Sağer MS, Sonmezoglu K.   +3 more
europepmc   +1 more source

Validity of the recorded International Classification of Diseases, 10th edition diagnoses codes of bone metastases and skeletal-related events in breast and prostate cancer Patients

, 2009
Annette Østergaard Jensen, Mette Nørgaard, M. Yong, J. Fryzek, Henrik Toft Sørensen   +4 more
openalex   +1 more source

EP-1432: Predicting pain response after conventional radiotherapy in 1018 patients with bone metastases

, 2016
Joanne M. van der Velden, H.M. Verkooijen, Anne Versteeg, A.S. Gerlich, Jorrit‐Jan Verlaan, L. Zhang, Min-Jen Tsao, Cyril Danjoux, Elizabeth Barnes, Marco van Vulpen, Eric J. Chow   +10 more
openalex   +1 more source

Artificial Intelligence for Bone: Theory, Methods, and Applications

Advanced Intelligent Discovery, EarlyView.
Advances in artificial intelligence (AI) offer the potential to improve bone research. The current review explores the contributions of AI to pathological study, biomarker discovery, drug design, and clinical diagnosis and prognosis of bone diseases. We envision that AI‐driven methodologies will enable identifying novel targets for drugs discovery. The
Dongfeng Yuan, Haicang Zhang, Liping Tong, Di Chen   +3 more
wiley   +1 more source

Anatomical distribution of bone metastases in stage IV breast cancer: According to histological subtype. [PDF]

World J Clin Oncol
Zari DS, Novak R, Haviv O, Ron I, Kaplan B, Awad B, Norman D, Nikomarov D.   +7 more
europepmc   +1 more source

A Murine Bispecific Antibody Efficiently Redirects T Cells Against Calr Mutated Stem Cells In Vivo

American Journal of Hematology, EarlyView.
ABSTRACT Calreticulin (CALR) mutations are prevalent in 20%–30% of patients with BCR::ABL1‐negative myeloproliferative neoplasms (MPN). Mutant calreticulin (mutCALR), presented by the thrombopoietin receptor (MPL, also known as TPOR or CD110) on the surface of the disease‐initiating MPN progenitors, represents an ideal target for curative ...
Shengen Xiong, Tamara Wais, Cecilia Varga, Christina Schueller, Sarada Achyutuni, Robert Kralovics   +5 more
wiley   +1 more source

Stereotactic body radiotherapy for spine and non-spine bone metastases in prostate carcinoma - a multicenter cohort analysis. [PDF]

J Bone Oncol
Nägler F, Seiler I, Schäfer S, Meents J, Lohaus F, Grün A, Wittenstein O, Klischies K, Remmele J, Rühle A, Eckl M, Blanck O, Boda-Heggemann J, Giordano FA, Moustakis C, Nicolay NH, Kästner L.   +16 more
europepmc   +1 more source

Adjuvant pamidronate therapy prevents the development of bone metastases in breast cancer patients with four or more positive nodes

, 2010
Ikuo Kokufu, Norio Kohno, Masayuki Yamamoto, Shintaro Takao   +3 more
openalex   +2 more sources